Abstract:Single-cell analysis has received much attention in recent years for elucidating the widely existing cellular heterogeneity in biological systems. However, the ability to measure the proteome in single cells is still far behind that of transcriptomics due to the lack of sensitive and high-throughput mass spectrometry methods. Herein, we report an integrated strategy termed "SCP-MS1" that combines fast liquid chromatography (LC) separation, deep learning-based retention time (RT) prediction and MS1-only acquisition for rapid and sensitive single-cell proteome analysis. In SCP-MS1, the peptides were identified via four-dimensional MS1 feature (m/z, RT, charge and FAIMS CV) matching, therefore relieving MS acquisition from the time consuming and information losing MS2 step and making this method particularly compatible with fast LC separation. By completely omitting the MS2 step, all the MS analysis time was utilized for MS1 acquisition in SCP-MS1 and therefore led to 65%-138% increased MS1 feature collection. Unlike "match between run" methods that still needed MS2 information for RT alignment, SCP-MS1 used deep learning-based RT prediction to transfer the measured RTs in long gradient bulk analyses to short gradient single cell analyses, which was the key step to enhance both identification scale and matching accuracy. Using this strategy, more than 2000 proteins were obtained from 0.2 ng of peptides with a 14-min active gradient at a false discovery rate (FDR) of 0.8%. Comparing with the DDA method, improved quantitative performance was also observed for SCP-MS1 with approximately 50% decreased median coefficient of variation of quantified proteins. For single-cell analysis, 1715 ± 204 and 1604 ± 224 proteins were quantified in single 293T and HeLa cells, respectively. Finally, SCP-MS1 was applied to single-cell proteome analysis of sorafenib resistant and non-resistant HepG2 cells and revealed clear cellular heterogeneity in the resistant population that may be masked in bulk studies.

On the utility of ultrafast MS1-only proteomics in drug target discovery studies based on thermal proteome profiling method

A Rapid and Sensitive Single-Cell Proteomic Method Based on Fast Liquid-Chromatography Separation, Retention Time Prediction and MS1-only Acquisition.

High-throughput Drug Target Discovery Using a Fully Automated Proteomics Sample Preparation Platform.

Precipitate-Supported Thermal Proteome Profiling Coupled with Deep Learning for Comprehensive Screening of Drug Target Proteins

A Proteomic Landscape of Pharmacologic Perturbations for Functional Relevance

Ultra-Fast Multi-Organ Proteomics Unveils Tissue-Specific Mechanisms of Drug Efficacy and Toxicity

Subcellular thermal profiling enables the deep functional exploration of the mitochondrial proteome

Scaled-Down Thermal Profiling and Coaggregation Analysis of the Proteome for Drug Target and Protein Interaction Analysis

[Thermal proteome profiling: a technique for a comprehensive assessment of protein status]

Ultra-high-throughput mass spectrometry in drug discovery: fundamentals and recent advances

Identifying drug targets in tissues and whole blood with thermal-shift profiling

Matrix Thermal Shift Assay for Fast Construction of Multidimensional Ligand–Target Space

Thermostability-assisted limited proteolysis-coupled mass spectrometry for capturing drug target proteins and sites

Integrated Thermal Proteome Profiling and Affinity Ultrafiltration Mass Spectrometry (iTPAUMS): A Novel Paradigm for Elucidating the Mechanism of Action of Natural Products

Membrane mimetic thermal proteome profiling (MM-TPP) towards mapping membrane protein-ligand dynamics

Network integration of thermal proteome profiling with multi-omics data decodes PARP inhibition

Ultrafast Proteomics

Proteome thermal stability reflects organ physiology and identifies drug-target engagement in vivo

Real-Time Monitoring of Pharmacokinetics of Mitochondria-Targeting Molecules in Live Cells with Bioorthogonal Hyperspectral Stimulated Raman Scattering Microscopy.

High-Throughput Native Mass Spectrometry Screening in Drug Discovery

Automated MALDI Target Preparation Concept: Providing Ultra-High-Throughput Mass Spectrometry–Based Screening for Drug Discovery